Topical Solution Vehicle

DRUG4 trials

Sponsors

DUSA Pharmaceuticals, Inc.

Conditions

Actinic Keratosis

Phase 2

Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy

CompletedNCT02239679

DUSA Pharmaceuticals, Inc.Actinic Keratosis

Start: 2014-09-30End: 2016-09-30Updated: 2018-08-24

Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face

CompletedNCT02632110

DUSA Pharmaceuticals, Inc.Actinic Keratosis

Start: 2016-03-31End: 2016-09-12Updated: 2018-01-18

Phase 3

Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities

CompletedNCT02137785

DUSA Pharmaceuticals, Inc.Actinic Keratosis

Start: 2014-05-31End: 2015-03-31Updated: 2015-09-16

Unknown Phase

Twelve Month Follow-Up of CP0108

CompletedNCT02209012

DUSA Pharmaceuticals, Inc.Actinic Keratosis

Start: 2014-08-31End: 2016-04-30Updated: 2016-09-23

Related Papers

A Randomized Trial of Broad Area ALA–PDT for Field Cancerization Mitigation in High-Risk Patients

Journal of Drugs in Dermatology2020-04-016 citations